Invention Grant
- Patent Title: IAP antagonists
- Patent Title (中): IAP拮抗剂
-
Application No.: US13921467Application Date: 2013-06-19
-
Publication No.: US08889712B2Publication Date: 2014-11-18
- Inventor: Robert M. Borzilleri , Heidi L. Perez , Erik M. Stang , Kyoung S. Kim
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D401/12 ; C07D401/14 ; C07K7/02 ; A61K38/08 ; C07D413/14 ; A61K45/06 ; C07D401/04
Abstract:
There are disclosed compounds that modulate the activity of inhibitors of apoptosis (IAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
Public/Granted literature
- US20130338081A1 IAP ANTAGONISTS Public/Granted day:2013-12-19
Information query
